Dr. Stanley A. Plotkin, a renowned vaccine researcher, will be presented the Hamdan Award for Medical Research Excellence in the field of Vaccines on Dec. 16 at the Dubai International Conference for Medical Sciences.
“Stanley’s life work has been to develop some of the most powerful and effective vaccines to help the most vulnerable populations around the world,” Dr. Russel E. Kaufman, president and CEO of The Wistar Institute, said. “Many scientists hope to discover one great vaccine or drug in their lifetime that will better the world. You can count on both hands how many Stanley has created or helped to create. He’s a heavyweight in vaccinology, and it’s because of his scientific principles and perseverance.”
The Hamdan Award was established in 1999 and helps health institutes around the globe to promote research initiatives.
The majority of Plotkin’s 50-year career was spent as a professor of virology at Wistar from 1960 to 1991, where his research led to the creation of the rubella vaccine against German measles, which is still used worldwide.
Plotkin remains an emeritus professor at both Wistar and in the department of pediatrics at the University of Pennsylvania. He also is an adviser to major vaccine companies and has served as senior assistant surgeon with Epidemic Intelligence Service, director of the Division of Infectious Disease at The Children’s Hospital of Philadelphia, associate chairman of the Department of Pediatrics at the University of Pennsylvania, and medical and scientific director at Aventis Pasteur.
Plotkin is also a former editor of Vaccines and has authored more than 700 publications.
During the Dubai conference, he will speak about the future of vaccine development and will also host a workshop on vaccines.